Learn More
Medchemexpress LLC Lysophosphatidylcholine 18:2 | 22252-07-9 | 99.1% | 519.65 | 10 MG

Supplier: Medchemexpress LLC HYN941010MG
Lysophosphatidylcholine 18:2 is a lysophospholipid and a potential biomarker identified from insulin resistance (IR) polycystic ovary syndrome (PCOS). Low plasma levels of this compound predict impaired glucose tolerance, insulin resistance, type 2 diabetes, coronary artery disease, and memory impairment. This product is for research use only and not sold to patients.
- Lysophospholipid and endogenous metabolite
- Potential biomarker for insulin resistance (IR) polycystic ovary syndrome (PCOS)
- Associated with impaired glucose tolerance, insulin resistance, type 2 diabetes
- Implies inflammation, obesity, and memory impairment
- Contributes to the separation of IR PCOS and control groups
- For research use only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.